Plain-English translation of NCT05775159 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing two new medications called and to see if they can help treat advanced liver cancer and bile duct cancer. Researchers want to learn whether these medications work better when given alone or combined with other cancer drugs that already exist. The study will enroll about 294 people across multiple hospital centers.
Advanced liver and bile duct cancers are difficult to treat, and current options don't work well for everyone. This trial exists to see whether this medication—which works by helping your immune system fight cancer—could give patients a new, more effective treatment option, either on its own or by boosting how well existing cancer drugs work.
You would receive one of the new medications—either alone or combined with other cancer treatments—as part of your regular cancer care. The exact schedule and combination would depend on which group you're assigned to. You would have regular clinic visits to receive your medication, have blood tests and scans to monitor how you're responding, and provide a tumor sample to help researchers understand how the treatment is working.
AI-generated summary from trial data · Jul 2, 2026 · Not medical advice
United States